NDC 24208-040-41 - Xipere
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24208-040
- Requested NDC
- 24208-040-41
- Package NDCs from labels
- 24208-040-41, 24208-040-40, 24208-040-02, 24208-040-01
- Manufacturer
- Bausch & Lomb Incorporated | Alcami Carolinas Corporation
- Effective date
- 2025-10-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xipere - Bausch & Lomb Incorporated | Alcami Carolinas Corporation | Bausch & Lomb Incorporated | Alcami Carolinas Corporation | 2025-10-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24208-040-01 | Xipere | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-01 | Xipere | 1 in 1 TRAY | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-02 | Xipere | 0.9 mL in 1 VIAL | INJECTION, SUSPENSION | 0.9 | 7 | |
| 24208-040-40 | Xipere | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-40 | Xipere | 1 in 1 TRAY | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-41 | Xipere | 0.9 mL in 1 VIAL | INJECTION, SUSPENSION | 0.9 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 24208-040-40 | ML - Milliliter | 24208-040 | da6c08ed-251c-4030-bfaf-2d7e536d5c98 | 1 | 2023-01-09 |
| 24208-040-41 | ML - Milliliter | 24208-040 | 676b47a3-48f2-4885-932c-12f0b33f42bd | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SUTAB | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | c020e973-dccf-4862-999e-17db6209a48a | 2026-01-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Adrenal Support | ADRENALINUM, BERBERIS VULGARIS, ARGENTUM NITRICUM, NATRUM MURIATICUM, VANADIUM METALLICUM, OLEUM MORRHUAE, PETROLEUM | NaturalCare | cee52757-a86e-4251-b65f-954ac85f4e7e | 2026-01-30 | Warnings | 451W47IQ8X |
| Vital Female Sexual Energy | AGNUS CASTUS, ARNICA MONTANA, AVENA SATIVA, CAULOPHYLLUM THALICTROIDES, CINCHONA OFFICINALIS, DAMIANA, HYPOPHYSIS SUIS, L-ARGININE, NATRUM MURIATICUM, OOPHORINUM SUIS, PHOSPHORICUM ACIDUM, SABAL SERRULATA, SEPIA, THUJA OCCIDENTALIS | Liddell Laboratories, Inc. | 7b15d6fa-eb04-41d2-8a01-6e7408ccf4d3 | 2026-01-30 | Warnings | 451W47IQ8X |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 451W47IQ8X B22547B95K |
| CVS ULTRA FINE MOISTURIZING SALINE MIST | NASAL MIST | CVS | 44821c47-63f9-5d0a-e063-6394a90a555d | 2026-01-29 | Warnings | 451W47IQ8X |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | a5cc640f-c72d-49fa-b970-906c9ffd8629 | 2026-01-28 | Adverse reactions | F446C597KA |
| triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 92a1ded0-8e1a-4994-9c8a-89e84fc85c94 | 2026-01-28 | Adverse reactions | F446C597KA |
| Carboxymethylcellulose Sodium Eye Drops 0.5% | CARBOXYMETHYLCELLULOSE SODIUM EYE DROPS 0.5% | Aurolab | e8b4df3b-3d81-b3ca-e053-2a95a90af2ec | 2026-01-27 | Warnings | K679OBS311 |
| AURO-CMC | CARBOXYMETHYLCELLULOSE EYE DROPS 0.5% | Aurolab | e90b397f-fe64-8674-e053-2995a90a223f | 2026-01-27 | Warnings | K679OBS311 |
| Sodium Chloride | SODIUM CHLORIDE | Nephron Pharmaceuticals Corporation | a4edf2d5-a9ff-30d4-e053-2995a90a5650 | 2026-01-26 | Warnings, Adverse reactions | 451W47IQ8X |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | ASCLEMED USA INC. | b909659e-8dd5-4652-89f4-c4d6b741a855 | 2026-01-23 | Warnings, Adverse reactions | F446C597KA |
| POKONZA potassium chloride | POTASSIUM CHLORIDE | Carwin Pharmaceutical Associates, LLC | 2d938cbf-27aa-4f9c-a582-5564d3b72465 | 2026-01-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | NuCare Pharmaceuticals,Inc. | 5439cd3c-da8d-3b96-e054-00144ff8d46c | 2026-01-21 | Adverse reactions | F446C597KA |
| INSULIN DILUTING MEDIUM FOR Kirsty | WATER | Biocon Biologics Inc. | 3db1d482-7e1f-aec6-79ef-3f305b4d8277 | 2026-01-20 | Warnings, Adverse reactions | 059QF0KO0R |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | REMEDYREPACK INC. | 037efc03-22ab-45eb-9b0e-b125e4b5eb99 | 2026-01-20 | Adverse reactions | F446C597KA |
| Sodium Chloride | SODIUM CHLORIDE | ProPharma Distribution | 48d73434-e65b-dc98-e063-6294a90affa2 | 2026-01-20 | Adverse reactions | 451W47IQ8X |
| Equate Comfort Flow Sinus wash | SINUS WASH | WALMART INC | 9e911eef-ca99-9902-e053-2a95a90aab0e | 2026-01-19 | Warnings | 451W47IQ8X |
| EQUATE PREMIUM SALINE | SODIUM CHLORIDE 0.65% | Walmart Stores, Inc. | 1e17f022-f513-140d-e063-6394a90a379e | 2026-01-19 | Warnings | 451W47IQ8X |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Sportpharm LLC | cab0573d-e760-4ff5-a69f-0ce06cfdb97a | 2026-01-19 | Warnings, Adverse reactions | F446C597KA |
| TRIAMCINOLONE ACETONIDE | TRIAMCINOLONE ACETONIDE | Preferred Pharmaceuticals Inc. | 60973042-077c-4265-988c-ad381f560333 | 2026-01-19 | Adverse reactions | F446C597KA |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.